Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference
Accolade, Inc. (NASDAQ: ACCD) will present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 2:50 p.m. E.T. This event will include an audio webcast and presentation materials available on their investor relations website. Accolade specializes in personalized, technology-enabled healthcare solutions that help individuals navigate the healthcare system effectively. The company aims to empower users with over 90% consumer satisfaction and a Net Promoter Score (NPS) of 60.
- None.
- None.
SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the 39th Annual J.P. Morgan Healthcare Conference, including a presentation on Thursday, January 14, 2021 at 2:50 p.m. E.T. An audio webcast and related presentation materials will be available at ir.accolade.com.
About Accolade, Inc.
Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support from Accolade Health Assistants® and Clinicians, and integrated data and programs across mobile, online and phone, Accolade navigates people through the healthcare system with trust, empathy and ease. Employers offer Accolade to employees and their families as the single place to turn for all health, healthcare, and benefits questions or concerns, increasing their engagement in benefits and connecting them to high-quality providers and care. By empowering members to make better decisions about their health, Accolade can support members in lowering the cost and complexity of healthcare while achieving consumer satisfaction ratings over 90 percent and an NPS of 60.
Investor Contact:
Todd Friedman, Investor Relations, 484-532-5200, Todd.Friedman@accolade.com
Asher Dewhurst, Investor Relations, 443-213-0503, accolade@westwicke.com
Media Contact:
Megan Torres, Public Relations, 206-926-8180, Megan.Torres@accolade.com
Source: Accolade
FAQ
When is Accolade scheduled to present at the J.P. Morgan Healthcare Conference 2021?
Where can I find the audio webcast for Accolade's presentation?
What does Accolade, Inc. specialize in?
What is the consumer satisfaction rating for Accolade?
What is the Net Promoter Score (NPS) for Accolade?
